Seoul, South Korea

Sun J Riu

This inventor holds 1 USPTO granted patent. Top assignee: Korea Greencross Corporation. Active years: 1993.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sun J Riu: Innovator in Hantaan Virus Research

Introduction

Sun J Riu is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of virology, particularly in the development of vaccines. His work focuses on the Hantaan virus, which is crucial for public health.

Latest Patents

Sun J Riu holds a patent for the Hantaan virus strain ROK84/105 and the vaccine developed from it. The invention relates to the Hantaan virus and outlines a method for preparing a vaccine. The vaccine is created using the ROK84/105 strain isolated from the human body, which is injected into one-day-old suckling mice or rats. After a period of growth, the brain of the animal is harvested, treated, purified, and inactivated, with an adjuvant added to enhance the final product.

Career Highlights

Sun J Riu is associated with Korea Greencross Corporation, where he continues to advance his research in virology. His innovative approach to vaccine development has the potential to impact public health significantly.

Collaborations

Sun J Riu has worked alongside notable colleagues, including Chang N An and Ho Woo Lee. Their collaborative efforts contribute to the ongoing research and development in the field of infectious diseases.

Conclusion

Sun J Riu's work in developing a vaccine for the Hantaan virus showcases his dedication to advancing medical science. His contributions are vital for improving health outcomes and combating viral infections.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…